News – ONL Therapeutics

News

SBIR Award, $1M Investment Get ONL Therapeutics to Clinical Trials

November 12, 2014
Applications for Neuroprotection: The Next Therapeutic Category in Retina Medicine

October 11, 2014
ONL Therapeutics Wins Emerging Company Showcase at MichBio Expo

October 2, 2014
ONL ANNOUNCES LEADERSHIP CHANGES

October 29, 2013
ONL RECEIVES ORPHAN DRUG DESIGNATION FOR ONL-101 IN RETINAL DETACHMENT

March 19, 2013

Privacy Statement | Accessibility Statement | Terms of Use | Copyright All Rights Reserved ©2026